Status:
COMPLETED
Rehabilitation for Patients With COPD
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Kaiser Permanente
Nina Ireland Program in Lung Health
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40-95 years
Phase:
NA
Brief Summary
This study will examine COPD Wellness, a 10-week low-intensity pulmonary rehabilitation program consisting of group and home exercise, education, and social support can improve symptoms and increase p...
Detailed Description
Chronic obstructive pulmonary disease (COPD), one of the leading causes of death in the US, disproportionately affects low socioeconomic communities. While few interventions effectively modify the cou...
Eligibility Criteria
Inclusion
- Age: Are greater than or equal to 40 years
- Diagnosis: COPD Gold Stage Class B-D (symptomatic disease), COPD/Asthma overlap with symptoms
- Language: English
- Care Center: ZSFG, Community Health Center clinics, Federally Qualified Health Centers
- Availability: Able to participate in a 10-week, weekly course at the weekly scheduled time (can defer x 1)
Exclusion
- Planning to move out of the area within the next year
- Eligible for and desire to go to full intensity pulmonary rehabilitation. Participant has Medicare Part A and B OR have San Francisco Health Plan. For those that met these criteria, we will assist with referral to program
- Resides in any kind of long-term care facilities that is NOT Laguna Honda or the Mental Health Rehabilitation Facility
- Has a diagnosis of interstitial lung disease, pulmonary fibrosis, or cystic fibrosis
- Active, chronic lung infection, such as tuberculosis
- A history of a pulmonary embolism in the year (12 months) prior to recruitment
- History of a myocardial infarction in the year (12 months) prior to recruitment
- In the 12 weeks prior to recruitment, has had history of unstable heart disease (including valve disease), heart failure, or uncontrolled irregular heart beat
- Potential participants who have had the following will be re-assess for eligibility 6 weeks after the initial assessment:
- A pulmonary exacerbation or worsening of COPD/Asthma symptoms in the past 6 weeks
- History of an upper respiratory infection in the past 6 weeks
- History of an eye, chest, or abdominal surgery within the past 6 weeks
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT03287440
Start Date
September 1 2017
End Date
July 30 2020
Last Update
June 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zuckerberg San Francisco General Hospital and Trauma Center
San Francisco, California, United States, 94110